مرحبا يا اخوان
من فتره طويله وانا اتابع اسهم عرض وطلب
وبعد درسه متانيه قررت الدخول فيها
وللاسف الظاهر انى كنت شراره عليهم
شريت hec ونزل
واتبعته cvm وكذلك الحال للاخر
اتمنى ان لا يكونوا متابعين المنتدى لشطب اشتراكى معهم
ولكن انا مؤمن بان الاسهم محتاجه بعض الصبر
السؤال يا اخوان cvm نزل السهم بفعل خبر وتوقف عن مستوى 38%
وبما انى اجهل عالم الاخبار السؤال عن مدى تاثير الخبر على السهم فى المدى البعيد
CEL-SCI Announces Receipt of Compliance Notice From AMEX
WEDNESDAY, NOVEMBER 12, 2003 9:04 AM
- PR Newswire
CVM
1.12 -0.16
Enter Symbol:
Enter Keyword:
VIENNA, Va., Nov 12, 2003 /PRNewswire-FirstCall via Comtex/ -- CEL-SCI CORPORATION (CVM) announces that it has received a letter from the American Stock Exchange (AMEX) stating that CEL-SCI has evidenced compliance with the requirements necessary for continued listing on the American Stock Exchange, based on the provisions of Section 1003(a)(1) and 1003(a)(2) of the AMEX Company Guide. CEL-SCI's continuing listing eligibility will be assessed on an ongoing basis.
CEL-SCI Corporation is developing new immune system-based treatments for cancer and infectious diseases. The Company has operations in Vienna, Virginia and Baltimore, Maryland.
SOURCE CEL-SCI Corporation
من فتره طويله وانا اتابع اسهم عرض وطلب
وبعد درسه متانيه قررت الدخول فيها
وللاسف الظاهر انى كنت شراره عليهم
شريت hec ونزل
واتبعته cvm وكذلك الحال للاخر
اتمنى ان لا يكونوا متابعين المنتدى لشطب اشتراكى معهم
ولكن انا مؤمن بان الاسهم محتاجه بعض الصبر
السؤال يا اخوان cvm نزل السهم بفعل خبر وتوقف عن مستوى 38%
وبما انى اجهل عالم الاخبار السؤال عن مدى تاثير الخبر على السهم فى المدى البعيد
CEL-SCI Announces Receipt of Compliance Notice From AMEX
WEDNESDAY, NOVEMBER 12, 2003 9:04 AM
- PR Newswire
CVM
1.12 -0.16
Enter Symbol:
Enter Keyword:
VIENNA, Va., Nov 12, 2003 /PRNewswire-FirstCall via Comtex/ -- CEL-SCI CORPORATION (CVM) announces that it has received a letter from the American Stock Exchange (AMEX) stating that CEL-SCI has evidenced compliance with the requirements necessary for continued listing on the American Stock Exchange, based on the provisions of Section 1003(a)(1) and 1003(a)(2) of the AMEX Company Guide. CEL-SCI's continuing listing eligibility will be assessed on an ongoing basis.
CEL-SCI Corporation is developing new immune system-based treatments for cancer and infectious diseases. The Company has operations in Vienna, Virginia and Baltimore, Maryland.
SOURCE CEL-SCI Corporation